Effects on Immunological and Virological Outcome of Patients Using One Protease Inhibitor or One Non-Nucleoside Reverse Transcriptase Inhibitor in a Triple Antiretroviral Therapy: Normal Clinical Practice Versus Clinical Trial Findings

By  

Current HIV Research, Vol. 3, Iss. 3, 2005-07 ,pp. : 271-276

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluating the Role of Etravirine in the Second-Line Antiretroviral Therapy After Failing an Initial Non-Nucleoside Reverse Transcriptase Inhibitor- Based Regimen in a Resource-Limited Setting§

By  

Current HIV Research, Vol. 6, Iss. 5, 2008-09 ,pp. : 474-476

Bentham Science Publishers

Access to resources Recommend Favorite

Conformational Changes in HIV-1 Reverse Transcriptase Induced by Nonnucleoside Reverse Transcriptase Inhibitor Binding

By  

Current HIV Research, Vol. 2, Iss. 4, 2004-10 ,pp. : 323-332

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of Residues in the Nonnucleoside Reverse Transcriptase Inhibitor Binding Pocket on HIV-1 Reverse Transcriptase Heterodimer Stability

By  

Current HIV Research, Vol. 6, Iss. 2, 2008-03 ,pp. : 130-137

Bentham Science Publishers

Access to resources Recommend Favorite

Direct, DNA Pol-γ-Independent Effects of Nucleoside Reverse Transcriptase Inhibitors on Mitochondrial Bioenergetics

By Lund Kaleb C.   Wallace Kendall B.  

Cardiovascular Toxicology, Vol. 4, Iss. 3, 2004-08 ,pp. : 217-228

Humana Press, Inc

Access to resources Recommend Favorite